Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Joslin-Beth Israel Deaconess Foot Center is a premier multidisciplinary clinical and research center dedicated to the management of diabetic foot complications. A collaborative effort between Joslin Diabetes Center and Beth Israel Deaconess Medical Center, the center integrates podiatric medicine, vascular surgery, and infectious disease expertise. It is globally recognized for its success in reducing amputation rates through advanced wound care protocols and innovative surgical interventions. Beyond clinical care, the center is a hub for clinical trials and research into diabetic neuropathy and microvascular disease. It serves as a critical resource for patients with high-risk diabetic foot conditions in the New England region and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Joslin-Beth Israel Deaconess Foot Center.